# A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy Adults

> **NCT07697846** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing QL Biopharmaceutical Co.,Ltd** · enrollment: 40 (estimated)

## Conditions studied

- Overweight, Obesity

## Interventions

- **DRUG:** ZT002 injection
- **DRUG:** ZT002 injection matching placebo

## Key facts

- **NCT ID:** NCT07697846
- **Lead sponsor:** Beijing QL Biopharmaceutical Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-18
- **Primary completion:** 2027-01-13
- **Final completion:** 2027-03-24
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07697846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07697846, "A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy Adults". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07697846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*